| FCPT price | $25.30 at the August 3, 2026, 4:00 PM EDT market close, down 0.30 or 1.17% from the $25.60 July 31 close, after opening at $25.49 and trading in a session range of $25.22 to $25.83, with the daily history table confirming the $25.30 close on volume near 753,000 shares | StockAnalysis.com real-time quote and daily price history | August 4, 2026 |
| Market capitalization | Near $2.78 billion, reported by StockAnalysis.com at the August 3, 2026 market close and verified as $25.30 times 109.87 million shares outstanding with a 0.01% deviation in the financial_rigor.py market cap check | StockAnalysis.com quote and financial_rigor.py verification | August 4, 2026 |
| Shares outstanding | 109.87 million shares outstanding, up 9.24% year over year, with a float of 108.33 million shares and institutions holding about 104.29% of shares outstanding | StockAnalysis.com statistics | August 4, 2026 |
| TTM revenue and net income | $306.40 million trailing twelve month revenue and $118.58 million TTM net income, with TTM EPS of $1.10 on the statistics page and $1.11 on the financials page | StockAnalysis.com statistics and financials | August 4, 2026 |
| FY2025 revenue | $294.13 million, up 9.72% from $268.07 million, with Real Estate Operations at $262.25 million and Restaurant Operations at $31.48 million | StockAnalysis.com financials | August 4, 2026 |
| FY2025 net income | $112.36 million, up 11.84% from $100.47 million, matching SEC EDGAR XBRL for the fiscal year ended December 31, 2025 | StockAnalysis.com financials and SEC EDGAR XBRL | August 4, 2026 |
| Q2 2026 revenue and net income | Q2 2026 revenue of $78.42 million, up 7.66% year over year, net income of $30.00 million, and net income attributable to common shareholders of $29.96 million or $0.27 per diluted share, with net income matching SEC EDGAR XBRL for the quarter ended June 30, 2026 | StockAnalysis.com income statement and SEC EDGAR XBRL | August 4, 2026 |
| Q2 2026 AFFO and rental income | Q2 AFFO per share of $0.45, up 1.4% from the prior year, Q2 cash rental income of $70.0 million, up 8.7% year over year, and annualized cash-based rent for leases in place of $270.5 million as of quarter end | FCPT Q2 2026 earnings call | August 4, 2026 |
| Portfolio occupancy and rent coverage | Occupancy above 99.5%, rent collection of 99.7% of base rent for Q2, rent coverage of 5.2x for the reporting majority of the portfolio, and 6.0x coverage on the Darden properties | FCPT Q2 2026 earnings call | August 4, 2026 |
| 2026 year-to-date investment | Year-to-date acquisition of $382 million of properties at a blended 6.6% cash cap rate through July, with Q2 adding 23 properties for $57 million at a 6.8% cash cap rate weighted toward automotive at 64% of volume, including a $26 million Sun Auto Tire & Service portfolio | FCPT Q2 2026 earnings call | August 4, 2026 |
| Mission Pet Health acquisition | Closed the 102 property Mission Pet Health portfolio for $268 million early in Q3, the largest acquisition in company history, with about $17.4 million of annualized cash rent, roughly 2% annual rent growth, two institutional master leases with about 10 years remaining, unit-level coverage over 6x, and an average basis of about $2.6 million per property | FCPT Q2 2026 earnings call | August 4, 2026 |
| Balance sheet and financing | Since April, FCPT closed $600 million of term loans including a $200 million seven-year facility at SOFR plus 125 basis points and a $400 million five-year facility at SOFR plus 90 basis points, with all-in rates around 4.5% to 4.9%, a fully undrawn $350 million revolver, run-rate leverage below the 6x upper bound of the stated 5x to 6x range, and a pro forma weighted average debt tenor of 4.3 years | FCPT Q2 2026 earnings call | August 4, 2026 |
| Cash, debt, and net debt | Cash and cash equivalents of $24.79 million as of June 30, 2026, matching SEC EDGAR XBRL, total debt near $1.25 billion on the StockAnalysis.com balance sheet and $1.265 billion on the XBRL debt instrument carrying amount, and net cash of negative $1.22 billion or about $11.10 per share | StockAnalysis.com balance sheet and SEC EDGAR XBRL | August 4, 2026 |
| Dividend and yield | Annual dividend of $1.47 per share, a 5.80% dividend yield, monthly payments with a first monthly dividend of $0.1222 declared for the August 31, 2026 ex-dividend date, a GAAP payout ratio near 154%, 4 years of dividend growth, and a buyback yield of negative 9.24% reflecting equity issuance | StockAnalysis.com dividend page and statistics | August 4, 2026 |
| Valuation ratios | 23.00x trailing PE, 21.80x forward PE, 14.94x trailing price to FFO, 9.07x price to sales, 1.71x price to book, and a 5.80% dividend yield at the $25.30 price | StockAnalysis.com statistics | August 4, 2026 |
| Analyst consensus | Buy with an average 12-month target of $28.22 across 9 analysts, low $26, median $28, and high $30, with the July 2026 rating mix at 2 Strong Buy, 2 Buy, and 5 Hold | StockAnalysis.com forecast | August 4, 2026 |
| Recent analyst target updates | Barclays lowered its target to $29 from $30 on July 22 with a Hold, Wells Fargo held $26 on July 16, UBS held $30 with a Buy on July 9, Huntington initiated with Outperform and a $27 target in July, Evercore ISI raised to $27 from $26 on April 30, and BMO held $27 on April 30 | StockAnalysis.com forecast and analyst ratings | August 4, 2026 |
| Consensus financial forecast | FY2026 revenue estimate of $293.29 million, FY2027 revenue of $341.24 million, FY2026 EPS estimate of $1.18 rising 8.26%, FY2026 FFO per share estimate of $1.77 with a 14.29x P/FFO, and FY2026 dividend estimate of $1.47 | StockAnalysis.com forecast financial forecast | August 4, 2026 |
| Short interest | 3.93 million shares short, 3.57% of shares outstanding, 3.62% of float, and 4.16 days to cover, up from 3.42 million shares short the prior month | StockAnalysis.com statistics short selling | August 4, 2026 |
| Technical snapshot | 50-day moving average near $25.17 and 200-day moving average near $24.63 on StockAnalysis.com statistics, 20-day moving average near $25.69 computed from the StockAnalysis.com daily price history, 14-day RSI near 46.46, beta of 0.81, 20-day average volume near 719,900 shares, and a 52-week range of $22.78 to $26.86 | StockAnalysis.com statistics and daily price history | August 4, 2026 |
| Portfolio diversification | Pro forma for Mission Pet Health, roughly 41% of cash rent now comes from outside casual dining, including medical retail at about 16%, auto service at about 13%, and quick service restaurants at about 10%, with Darden at about 41% of cash rent and the original spin-off portfolio now about 29% of properties owned | FCPT Q2 2026 earnings call | August 4, 2026 |
| Data source gap | FFO and AFFO per share for the trailing twelve months were inferred from the price to FFO ratio rather than sourced from the company supplemental. The StockAnalysis.com statistics page reports cash and cash equivalents of $40.09 million under S&P Global classification, while the StockAnalysis.com balance sheet page and SEC EDGAR XBRL show $24.79 million as of June 30, 2026; this page uses the balance sheet and XBRL figure as primary. Company-provided occupancy, rent coverage, and investment pipeline metrics should be checked against the FCPT investor relations page and supplemental report for the most accurate current data. | StockAnalysis.com financials and FCPT investor relations | August 4, 2026 |